Streetbeat News

Stock Prices

NOW

ServiceNow (NYSE:NOW) has seen significant bearish options trading activity, with 40% of traders showing bearish tendencies. The stock is currently trading at $919.06, slightly down by 0.02%. An analyst from Needham downgraded its rating to Buy with a price target of $900. The anticipated earnings release is in 33 days.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 4:17 pm

AMAT

Whales are showing a bearish stance on Applied Materials (NASDAQ:AMAT) through options trading, with 40% of trades being bearish. The price range targeted is $140 to $210. Analysts have mixed ratings, with target prices ranging from $185 to $217.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 4:16 pm

GLE

The trading halt for an IPO security has been updated, and it is now released for quotation as of 12:15 PM ET.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:15 pm

FBIO

Fortress Biotech (FBIO) shares dropped 18.5% after announcing an $8 million direct offering and private placements. The company sold shares at $1.65 each and issued warrants at $1.84. The stock has fallen significantly over the past year.

Portfolio Pulse from Henry Khederian

September 20, 2024 | 4:15 pm

RIVN

Rivian Automotive Inc (NASDAQ:RIVN) shares fell 7.5% to $12.17 as major indexes pulled back. Despite a recent Federal Reserve rate cut, which initially boosted Rivian's stock, concerns over the company's cash burn and economic conditions have weighed on investor sentiment. Rivian remains in a growth phase with significant capital expenditures and has yet to turn a profit. Analysts generally view Rivian as an outperformer, with some expecting significant stock price increases.

Portfolio Pulse from Henry Khederian

September 20, 2024 | 4:11 pm

MEDS

Trxade Health, Inc. has announced a name change to Scienture Holdings. The company's stock will begin trading under the new ticker symbol SCNX starting September 23.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:10 pm

NVO

Novo Nordisk shares are trading lower following the release of results from its Phase 2a trial of Monlunabant in obesity.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:09 pm

DJT

Trump Media & Technology Group Corp. (NASDAQ:DJT) shares are declining as the lockup period for some investors has expired, allowing them to sell shares. Despite Trump's assurance of not selling his shares, the stock has fallen over 20% in the past five days and is down nearly 75% since its SPAC merger debut.

Portfolio Pulse from Erica Kollmann

September 20, 2024 | 4:07 pm

FDX

FedEx Corp (NYSE:FDX) experienced a significant stock drop of over 15% following a disappointing earnings report. The company reported lower-than-expected revenue and earnings due to decreased U.S. domestic priority package volumes and rising costs. FedEx has revised its full-year guidance downward, projecting low single-digit revenue growth for fiscal year 2025. Analysts have responded with downgrades and reduced price targets, and technical indicators suggest a bearish trend.

Portfolio Pulse from Surbhi Jain

September 20, 2024 | 4:04 pm

VLO

Valero Energy's stock is experiencing a decline following a downgrade by Piper Sandler from Overweight to Neutral, with a reduced price target from $169 to $123.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:04 pm